vix.ing · top · new · best · stats · spec

Denái R. Milton

  1. Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma
    2025/07/10 by Elizabeth M. Burton, Denái R. Milton, Michael T. Tetzlaff +25 · 11 citations
    Medicine · #Cancer Immunotherapy and Biomarkers #Cutaneous Melanoma Detection and Management #CAR-T cell therapy research